IFNG and pneumococcal meningitis: 2014; Yau et al. 2017; Bewersdorf et al. 2018). IFN-γ antibody treatment improved survival after pneumococcal meningitis and overall clinical symptoms were less compared to non-treated animals. Interestingly, bacterial burdens were unaffected by this treatment (Pettini et al. 2015).